1 completed, 1 terminated, 1 withdrawn. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Terminated 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Sturge Weber Syndrome: new trials by email Literature Review of Sturge Weber Syndrome trials Research Report on Sturge Weber Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Adjunctive Everolimus (RAD 001) Therapy for Epilepsy in Children With Sturge-Weber Syndrome (SWS) Everolimus - Sturge Weber Syndrome | Phase 2 | Withdrawn | Baylor College of Medicine | 2014-04-01 | 2016-05-05 | |
| Treatment of Port-wine Mark in Sturge-Weber Syndrome Using Topical Timolol Timolol, Preservative free artificial tear gel. - Sturge Weber Syndrome, Port-wine Mark | Phase 1 | Terminated | Wills Eye | 3 | 2012-02-01 | 2019-03-21 |
| Use of the Atkins Diet for Children With Sturge Weber Syndrome modified Atkins diet - Epilepsy, Sturge Weber Syndrome | Phase 1 | Completed | Johns Hopkins University | 5 | 2006-05-01 | 2010-05-27 |
Sturge-Weber Syndrome (3) · Epilepsy (2) · Glaucoma (1) · Port-Wine Stain (1)
Angiomatosis (3) · Cardiovascular Diseases (3) · Hemangioma (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Neoplasms, Vascular Tissue (3) · Nervous System Diseases (3) · Neurocutaneous Syndromes (3) · Vascular Diseases (3) · Brain Diseases (2) · Central Nervous System Diseases (2) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Eye Diseases (1) · Ocular Hypertension (1)
Everolimus (1) · Timolol (1)
Baylor College of Medicine (1) · Johns Hopkins University (1) · Wills Eye (1)
United States (3)
Alex V Levin, MD, MHSc (1) · Angus A Wilfong, MD (1) · Eric H Kossoff, MD (1)